Effect of the ASCENT Intervention to Increase Knowledge of Kidney Allocation Policy Changes Among Dialysis Providers
Overview
Authors
Affiliations
Introduction: The Allocation System Changes for Equity in Kidney Transplantation (ASCENT) trial was a cluster-randomized pragmatic, effectiveness-implementation study designed to test whether a multicomponent educational intervention targeting leadership, clinic staff, and patients in dialysis facilities improved knowledge and awareness of the 2014 Kidney Allocation System (KAS) change.
Methods: Participants included 690 dialysis facility medical directors, nephrologists, social workers, and other staff within 655 US dialysis facilities, with 51% ( = 334) in the intervention group and 49% ( = 321) in the control group. Intervention activities included a webinar targeting medical directors and facility staff, an approximately 10-minute educational video targeting dialysis staff, an approximately 10-minute educational video targeting patients, and a facility-specific audit and feedback report of transplant performance. The control group received a standard United Network for Organ Sharing brochure. Provider knowledge was a secondary outcome of the ASCENT trial and the primary outcome of this study; knowledge was assessed as a cumulative score on a 5-point Likert scale (higher score = greater knowledge). Intention-to-treat analysis was used.
Results: At baseline, nonintervention providers had a higher mean knowledge score (mean ± SD, 2.45 ± 1.43) than intervention providers (mean ± SD, 2.31 ± 1.46). After 3 months, the average knowledge score was slightly higher in the intervention (mean ± SD, 3.14 ± 1.28) versus nonintervention providers (mean ± SD, 3.07 ± 1.24), and the estimated mean difference in knowledge scores between the groups at follow-up minus the mean difference at baseline was 0.25 (95% confidence interval [CI], 0.11-0.48; = 0.039). The effect size (0.41) was low to moderate.
Conclusion: Dialysis facility provider education could help extend the impact of a national policy change in organ allocation.
Patzer R, Buford J, Urbanski M, McPherson L, Paul S, Di M Clin J Am Soc Nephrol. 2024; .
PMID: 39671258 PMC: 11835189. DOI: 10.2215/CJN.0000000586.
Implementation of the ASCENT Trial to Improve Transplant Waitlisting Access.
Urbanski M, Lee Y, Escoffery C, Buford J, Plantinga L, Pastan S Kidney Int Rep. 2024; 9(2):225-238.
PMID: 38344743 PMC: 10851002. DOI: 10.1016/j.ekir.2023.10.028.
Buford J, Retzloff S, Wilk A, McPherson L, Harding J, Pastan S Kidney Med. 2023; 5(10):100706.
PMID: 37753250 PMC: 10518364. DOI: 10.1016/j.xkme.2023.100706.
Patzer R, Retzloff S, Buford J, Gander J, Browne T, Jones H Curr Transplant Rep. 2022; 8(4):324-332.
PMID: 36059891 PMC: 9435919. DOI: 10.1007/s40472-021-00346-x.
Why Policy Changes May Be Necessary but Not Sufficient in Overcoming Disparities.
Waterman A, Rossi A, Wood E, Ranasinghe O Kidney Int Rep. 2020; 5(9):1385-1386.
PMID: 32955517 PMC: 7486334. DOI: 10.1016/j.ekir.2020.07.037.